These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19553066)

  • 1. Health-related quality of life trajectories of methamphetamine-dependent individuals as a function of treatment completion and continued care over a 1-year period.
    Gonzales R; Ang A; Marinelli-Casey P; Glik DC; Iguchi MY; Rawson RA;
    J Subst Abuse Treat; 2009 Dec; 37(4):353-61. PubMed ID: 19553066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical course and outcomes of methamphetamine-dependent adults with psychosis.
    Glasner-Edwards S; Mooney LJ; Marinelli-Casey P; Hillhouse M; Ang A; Rawson R;
    J Subst Abuse Treat; 2008 Dec; 35(4):445-50. PubMed ID: 18294802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug court treatment for methamphetamine dependence: treatment response and posttreatment outcomes.
    Marinelli-Casey P; Gonzales R; Hillhouse M; Ang A; Zweben J; Cohen J; Hora PF; Rawson RA;
    J Subst Abuse Treat; 2008 Mar; 34(2):242-8. PubMed ID: 17596903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic Review.
    Siefried KJ; Acheson LS; Lintzeris N; Ezard N
    CNS Drugs; 2020 Apr; 34(4):337-365. PubMed ID: 32185696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methamphetamine-Associated Congestive Heart Failure: Increasing Prevalence and Relationship of Clinical Outcomes to Continued Use or Abstinence.
    Sliman S; Waalen J; Shaw D
    Cardiovasc Toxicol; 2016 Oct; 16(4):381-9. PubMed ID: 26661075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of an exercise intervention on methamphetamine use outcomes post-residential treatment care.
    Rawson RA; Chudzynski J; Mooney L; Gonzales R; Ang A; Dickerson D; Penate J; Salem BA; Dolezal B; Cooper CB
    Drug Alcohol Depend; 2015 Nov; 156():21-28. PubMed ID: 26371404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence.
    Longo M; Wickes W; Smout M; Harrison S; Cahill S; White JM
    Addiction; 2010 Jan; 105(1):146-54. PubMed ID: 19839966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duration effects in contingency management treatment of methamphetamine disorders.
    Roll JM; Chudzynski J; Cameron JM; Howell DN; McPherson S
    Addict Behav; 2013 Sep; 38(9):2455-62. PubMed ID: 23708468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risks of psychosis in methamphetamine users: cross-sectional study in Thailand.
    Lamyai W; Pono K; Indrakamhaeng D; Saengsin A; Songhong N; Khuwuthyakorn P; Sribanditmongkol P; Junkuy A; Srisurapanont M
    BMJ Open; 2019 Oct; 9(10):e032711. PubMed ID: 31615802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life among treatment seeking methamphetamine-dependent individuals.
    Gonzales R; Ang A; Glik DC; Rawson RA; Lee S; Iguchi MY;
    Am J Addict; 2011; 20(4):366-72. PubMed ID: 21679268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health outcomes associated with methamphetamine use among young people: a systematic review.
    Marshall BD; Werb D
    Addiction; 2010 Jun; 105(6):991-1002. PubMed ID: 20659059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurofeedback Training as a New Method in Treatment of Crystal Methamphetamine Dependent Patients: A Preliminary Study.
    Rostami R; Dehghani-Arani F
    Appl Psychophysiol Biofeedback; 2015 Sep; 40(3):151-61. PubMed ID: 25894106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between impulsivity and methamphetamine use severity in a community sample.
    Moallem NR; Courtney KE; Ray LA
    Drug Alcohol Depend; 2018 Jun; 187():1-7. PubMed ID: 29626740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex Differences in Methamphetamine Use and Dependence in a Thai Treatment Center.
    Rungnirundorn T; Verachai V; Gelernter J; Malison RT; Kalayasiri R
    J Addict Med; 2017; 11(1):19-27. PubMed ID: 27649265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of treatment utilization and methamphetamine use during first 10 years after methamphetamine initiation.
    Brecht ML; Lovinger K; Herbeck DM; Urada D
    J Subst Abuse Treat; 2013; 44(5):548-56. PubMed ID: 23313146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conditional Effects of Lifetime Alcohol Consumption on Methamphetamine-Associated Neurocognitive Performance.
    Saloner R; Paolillo EW; Umlauf A; Moore DJ; Heaton RK; Grant I; Cherner M;
    J Int Neuropsychol Soc; 2019 Sep; 25(8):787-799. PubMed ID: 31179969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Course of Psychiatric Symptoms and Abstinence among Methamphetamine-Dependent Persons in Sober Living Recovery Homes.
    Polcin DL; Witbrodt J; Korcha R; Gupta S; Mericle AA
    J Psychoactive Drugs; 2016; 48(3):173-80. PubMed ID: 27184803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychological function and delay discounting in methamphetamine-dependent individuals.
    Hoffman WF; Moore M; Templin R; McFarland B; Hitzemann RJ; Mitchell SH
    Psychopharmacology (Berl); 2006 Oct; 188(2):162-70. PubMed ID: 16915378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Criminal justice itreatment admissions for methamphetamine use in California: a focus on Proposition 36.
    Anglin MD; Urada D; Brecht ML; Hawken A; Rawson R; Longshore D
    J Psychoactive Drugs; 2007 Nov; Suppl 4():367-81. PubMed ID: 18284103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methamphetamine: geographic areas and populations at risk, and emerging evidence for effective interventions.
    Degenhardt L; Baker A; Maher L
    Drug Alcohol Rev; 2008 May; 27(3):217-9. PubMed ID: 18368601
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.